Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
13.17
+0.17 (1.31%)
At close: Mar 19, 2026, 4:00 PM EDT
13.00
-0.17 (-1.29%)
After-hours: Mar 19, 2026, 7:00 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $137.11 million as of March 19, 2026. Its market cap has increased by 24.85% in one year.
Market Cap
137.11M
Enterprise Value
-30.30M
1-Year Change
24.85%
Ranking
Category
Stock Price
$13.17
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $137.11M, a decrease of -89.45%. That is a compound annual growth rate of -35.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 539.76M | 6.57% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 145.28M |
| Agenus | 144.38M |
| Artiva Biotherapeutics | 143.36M |
| vTv Therapeutics | 142.97M |
| Oramed Pharmaceuticals | 142.09M |
| Spero Therapeutics | 138.59M |
| Inhibikase Therapeutics | 137.57M |
| Codexis | 133.58M |